✦ LIBER ✦

The challenges of developing novel antiparasitic drugs

✍ Scribed by Debra J. Woods; Tracey M. Williams

Publisher: Springer-Verlag
Year: 2007
Tongue: English
Weight: 153 KB
Volume: 7
Category: Article
ISSN: 1354-2516
DOI: 10.1007/s10158-007-0055-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel suicide inhibitor strategy for a

A novel suicide inhibitor strategy for antiparasitic drug development

✍ C. C. Wang 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 488 KB

DL-a-Difluoromethylornithine (DFMO), a suicide inhibitor of eukaryotic ornithine decarboxylase (ODC), has therapeutic activities against African trypanosomiasis. The K, value of DFMO for ODC of Trypanosoma brucei is somewhat higher than that for mouse ODC. The therapeutic efficacy of DFMO cannot the

Information-based methods in the develop

Information-based methods in the development of antiparasitic drugs

✍ Kristina Wolf; Matthias Dormeyer 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 333 KB

Formulation and biopharmaceutical issues

Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs

✍ O. Kayser; C. Olbrich; S. L. Croft; A. F. Kiderlen 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 321 KB

Challenges in the development of antimal

Challenges in the development of antimalarial drugs with causal prophylactic activity

✍ Jeffrey D. Chulay 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 433 KB

Strategy for the development of novel an

Strategy for the development of novel anticancer drugs

✍ Nagahiro Saijo; Tomohide Tamura; Kazuto Nishio 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 170 KB

Mutagenicity of products generated by th

Mutagenicity of products generated by the reaction between several antiparasitic drugs and nitrite

✍ Alba, M. Arriaga ;Espinosa, J. ;De Nava, C. Cortinas 📂 Article 📅 1988 🏛 Wiley (John Wiley & Sons) ⚖ 416 KB